Efficacy of a single 30-minute infusion of Xydalba is comparable to two doses 1 week apart10
The primary endpoint was a comparison of the proportion of patients in the intent-to-treat (ITT) population who achieved a ≥20% reduction in the size of the erythema 48–72 hours (±3 hours) after initiation of study drug and did not receive rescue antibacterial therapy.
Clinical status, defined as improvement in lesion size as well as resolution or improvement of clinical signs and symptoms, was performed at day 14 and day 28.
10 MW Dunne et al. Clinical Infectious Diseases. 2016;62(5):545–51